ESC Professional Premium Access

Beta3 adrenergic agonists in the clinic: the end of the beginning

Event: ESC Congress 2022
Topic: Pharmacology and Pharmacotherapy
Session type: Special Session
Date: 28 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Beta3 adrenergic receptors: where, and what for?

Speaker: Professor J. Balligand (Brussels, BE)
Thumbnail

Activation of beta3-AR with mirabegron in hypertrophic cardiomyopathy: the BETA3LVH trial.

Speaker: Associate Professor R. Wachter (Leipzig, DE)
Thumbnail

Mirabegron in patients with pulmonary hypertension: the SPHERE-HF trial.

Speaker: Doctor A. Garcia-Alvarez (Barcelona, ES)
Thumbnail

Mirabegron in peripheral vascular disease: the STAR-PAD trial.

Speaker: Doctor M. Gray (Sydney, AU)
Thumbnail

4 speakers from this session

Professor Jean-Luc Balligand

Catholic University of Louvain, Brussels (Belgium)
9 presentations
0 follower

Associate Professor Rolf Wachter

University hospital Leipzig AoR, Leipzig (Germany)
8 presentations
0 follower

Doctor Ana Garcia-Alvarez

Hospital Clinic, University of Barcelona, Barcelona (Spain)
1 presentation
0 follower

Doctor Michael Gray

royal north shore hospital, Sydney (Australia)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk